Letters and Comments

Joint Comment on FDA’s Draft Guidance for Sepsis Prevention in HCT/Ps

July 7, 2025
Letters and Comments

Joint Comment on FDA’s Draft Guidance: Reducing Mtb Risk in HCT/Ps

July 7, 2025
Letters and Comments

Blood Community Comment Letter on FDA Guidance for HCT/P Safety

April 7, 2025
Letters and Comments

Blood Community Comments on FDA’s Mtb Transmission Risk Guidance

April 7, 2025
Letters and Comments

FDA Draft Report Comments & Plan on Best Practices Guidance

February 23, 2024
ABC Newsletter

Convalescent Plasma Guidance Updated by FDA

October 20, 2023
ABC Newsletter

Blood Compliance Policy Guidance Published by FDA

October 20, 2023
ABC Newsletter

Donor Eligibility and Suitability Guidance Addressed by FDA

August 25, 2023
ABC Newsletter

FDA Updates Guidance Agenda

June 30, 2023